However, IFN-γ-hyperactivation negatively impacts several inflammatory and autoimmune diseases: rheumatoid arthritis, multiple sclerosis, Sjogren’s syndrome and inflammatory bowel disease (IBD) among others (6–10). This evidence concerns the gene IFNG and inflammatory bowel disease.